Could Frequent Carbapenem Use Be a Risk Factor for Colistin Resistance?

GÜNDOĞDU A., Ulu-Kilic A., KILIÇ H., OZHAN E., ALTUN D., CAKIR O., ...More

MICROBIAL DRUG RESISTANCE, no.6, pp.774-781, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Publication Date: 2018
  • Doi Number: 10.1089/mdr.2016.0321
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.774-781
  • Keywords: colistin-resistant A. baumannii, colistin-resistant K. pneumoniae, carbapenems usage, developing countries, outbreak, ACINETOBACTER-BAUMANNII, NEGATIVE BACTERIA, MECHANISMS, INFECTION
  • Erciyes University Affiliated: Yes


Aims: The antibiotic colistin, which had been previously abandoned, is being brought back as a last line of defense against bacterial infection. However, colistin resistance was reported shortly after its reintroduction. This study evaluated the risk factors for colonization/infections due to colistin-resistant Acinetobacter baumannii (ColR-Ab) and Klebsiella pneumoniae (ColR-Kp) strains and characterized the molecular epidemiology of these two strains. Results: Age, previous hospitalization duration, and previous use of carbapenem and colistin were risk factors for ColR-Kp, whereas previous use of carbapenem and colistin was a risk factor for ColR-Ab. According to pulsed-field gel electrophoresis analysis, most ColR-Kp strains could be grouped into two major pulsotypes. This appears to be an indicator of cross contamination of ColR-Kp strain, since different isolates appeared to be belonging to the same clones. The existence of colistin-susceptible (ColS) and colistin-resistant (ColR) strains in the same pulsotypes might also be an indicator of the recent emergence of resistance mechanisms. Conclusions: The results highlight the emergence of ColR pathogens in Turkey, which is considered to be developing country, and that carbapenem use coupled with insufficient infection control measures might increase the risk of ColR outbreaks.